Overview

HMPL004-6599 Phase I Dose-escalating Study

Status:
Terminated
Trial end date:
2018-11-19
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of single and multiple doses of HMPL004-6599 in healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Nutrition Science Partners Limited
Collaborators:
Hutchison Medipharma Limited
Nestlé